Duration of Bisphosphonate Effect in Hypercalcaemia — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — The calcium‑lowering effect typically lasts 4–6 weeks; recurrence should be anticipated and a repeat dose planned if symptoms return
Explanation lettering: C = shown as B · E = shown as C · B = shown as E
Option E is correct. UK clinical practice guidance (Kent and Medway Formulary) advises that a single bisphosphonate infusion will usually maintain normocalcaemia for about 3 weeks, emphasising that recurrence is expected and repeat dosing may be needed ([kentandmedwayformulary.nhs.uk](https://kentandmedwayformulary.nhs.uk/media/3p0kpxno/treatment-of-acute-hypercalcaemia-in-adults-2025-alt.pdf?utm_source=openai)). Furthermore, the UK SmPC for zoledronic acid reports a median time to relapse of hypercalcaemia of about 30–40 days, confirming that the effect typically lasts several weeks ([medicines.org.uk](https://www.medicines.org.uk/emc/product/11672/smpc?utm_source=openai)). Distractors: A (exactly 7 days) is overly short and precisely timed—contradicts evidence. B is incorrect—re-treatment is routine and supported. C is wrong—the effect is temporary. D (12 months) vastly overestimates typical duration.
Reference: Kent and Medway Formulary ‘Treatment of acute hypercalcaemia in adults’ (2025) and Zoledronic acid 4 mg SmPC (emc) (UK) – duration of normocalcaemia days to weeks